We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+4.9%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3.9B
AUM Growth
+$213M
Cap. Flow
+$73M
Cap. Flow %
1.87%
Top 10 Hldgs %
36.05%
Holding
3,497
New
199
Increased
1,347
Reduced
1,062
Closed
172
Avg Time Held Equity + Options
4.3 years
Top 10 Avg Time Held Equity + Options
2 years
Top 20 Avg Time Held Equity + Options
3.2 years
Avg Time Held Equity only
4.3 years
Top 10 Avg Time Held Equity only
2 years
Top 20 Avg Time Held Equity only
3.2 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.08%
2 Technology 16.58%
3 Healthcare 8.56%
4 Financials 6.53%
5 Communication Services 5.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MVST icon
3276
Microvast
MVST
$209M
$14 ﹤0.01%
30
– –
2021 Q1
13 quarters
ALZN icon
3277
Alzamend Neuro
ALZN
$6.37M
– –
0
– –
2023 Q4
2 quarters
AVTX icon
3278
Avalo Therapeutics
AVTX
$653M
$12 ﹤0.01%
1
– –
2020 Q1
17 quarters
HOS icon
3279
Hornbeck Offshore Services, Inc.
HOS
$2.17B
$12 ﹤0.01%
1
– –
2021 Q2
12 quarters
WHWK icon
3280
Whitehawk Therapeutics
WHWK
$173M
$12 ﹤0.01%
8
-161,188
-100% -$299K
2020 Q4
14 quarters
EHAB icon
3281
DELISTED
Enhabit
EHAB
$9 ﹤0.01%
1
– –
2022 Q3
7 quarters
DCTH icon
3282
Delcath Systems
DCTH
$511M
$8 ﹤0.01%
1
– –
2020 Q2
16 quarters
AAGR
3283
DELISTED
African Agriculture Holdings Inc
AAGR
$8 ﹤0.01%
30
– –
2022 Q1
9 quarters
KALA icon
3284
KALA BIO
KALA
$3.73M
– –
0
– –
2021 Q1
13 quarters
VIRX icon
3285
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$4 ﹤0.01%
8
– –
2018 Q4
22 quarters
AKTS icon
3286
DELISTED
Akoustis Technologies Inc
AKTS
$4 ﹤0.01%
30
– –
2020 Q4
14 quarters
CMAX icon
3287
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$3 ﹤0.01%
1
-6
-86% -$19
2023 Q2
4 quarters
CNSP icon
3288
CNS Pharmaceuticals
CNSP
$7.57M
– –
0
– –
2024 Q2
0 quarters
GWAV icon
3289
Greenwave Technology Solutions
GWAV
$2.07M
– –
0
– –
2023 Q1
5 quarters
IMUX icon
3290
Immunic
IMUX
$95.6M
– –
0
– –
2018 Q2
24 quarters
SEEL icon
3291
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
– –
0
– –
2021 Q1
13 quarters
CCO icon
3292
Clear Channel Outdoor Holdings
CCO
$1.23B
$1 ﹤0.01%
1
– –
2023 Q2
4 quarters
CLOV icon
3293
Clover Health Investments
CLOV
$2.49B
$1 ﹤0.01%
1
-3,009
-100% -$2.7K
2021 Q3
11 quarters
XXII
3294
22nd Century Group
XXII
$457K
– –
0
– –
2018 Q2
24 quarters
TVRD icon
3295
Tvardi Therapeutics
TVRD
$13.9M
– –
0
– –
2023 Q4
2 quarters
VRPX icon
3296
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
– –
0
– –
2023 Q4
2 quarters
ABM icon
3297
ABM Industries
ABM
$3B
– –
-11
Closed -$491 –
ACAD icon
3298
Acadia Pharmaceuticals
ACAD
$3.4B
– –
-194
Closed -$3.59K –
ACB icon
3299
Aurora Cannabis
ACB
$266M
– –
-100
Closed -$439 –
AHRT icon
3300
AH Realty Trust
AHRT
$445M
– –
-27
Closed -$281 –

Similar funds

Parallel Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Parallel Advisors held 3,497 positions worth $3.9B, up 5.8% from $3.69B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Parallel Advisors's Q2 2024 filing shows 199 new, 1,347 increased, 1,062 reduced and 172 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M. The largest sale was iShares MSCI USA Quality Factor ETF, an estimated $52.1M.

By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 49% a quarter earlier, followed by Technology and Healthcare.

  • Parallel Advisors's largest Q2 2024 buy was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $79.4M increase.
  • Parallel Advisors's biggest Q2 2024 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $52.1M.
  • Parallel Advisors fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $974K.
  • Parallel Advisors's ten largest holdings make up 36% of its $3.9B portfolio in Q2 2024.
  • Parallel Advisors opened 199 new positions and closed 172 in Q2 2024.
  • Parallel Advisors's portfolio value rose 5.8% quarter-over-quarter to $3.9B.

Based on Parallel Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.